121 related articles for article (PubMed ID: 31663414)
1. Educational level and first-time PSA testing in general practice.
Lerhmann-Lerche CS; Larsen SB; Andersen I; Thygesen LC; Kaae Andersen K; Duun-Henriksen AK; Johansen C; Røder MA; Brasso K; Dalton SO
Scand J Urol; 2019 Oct; 53(5):275-281. PubMed ID: 31663414
[No Abstract] [Full Text] [Related]
2. A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies.
Nordström T; Bratt O; Örtegren J; Aly M; Adolfsson J; Grönberg H
Scand J Urol; 2016; 50(2):104-9. PubMed ID: 26625178
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer incidence and survival in relation to education (United States).
Steenland K; Rodriguez C; Mondul A; Calle EE; Thun M
Cancer Causes Control; 2004 Nov; 15(9):939-45. PubMed ID: 15577296
[TBL] [Abstract][Full Text] [Related]
4. Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: an ecological study.
Hjertholm P; Fenger-Grøn M; Vestergaard M; Christensen MB; Borre M; Møller H; Vedsted P
Int J Cancer; 2015 Jan; 136(2):435-42. PubMed ID: 24905402
[TBL] [Abstract][Full Text] [Related]
5. Discrepancies between guidelines and clinical practice regarding prostate-specific antigen testing.
Hamoen EH; Reukers DF; Numans ME; Barentsz JO; Witjes JA; Rovers MM
Fam Pract; 2013 Dec; 30(6):648-54. PubMed ID: 24107269
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen testing rates and referral patterns from general practice data in England.
Moss S; Melia J; Sutton J; Mathews C; Kirby M
Int J Clin Pract; 2016 Apr; 70(4):312-8. PubMed ID: 26987766
[TBL] [Abstract][Full Text] [Related]
7. PSA testing without clinical indication for prostate cancer in relation to socio-demographic and clinical characteristics in the Danish Diet, Cancer and Health Study.
Karlsen RV; Larsen SB; Christensen J; Brasso K; Friis S; Tjønneland A; Dalton SO
Acta Oncol; 2013 Nov; 52(8):1609-14. PubMed ID: 23978293
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
Jønler M; Eddy B; Poulsen J
Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
[TBL] [Abstract][Full Text] [Related]
9. Socioeconomic position, referral and attendance to rehabilitation after a cancer diagnosis: A population-based study in Copenhagen, Denmark 2010-2015.
Oksbjerg Dalton S; Halgren Olsen M; Moustsen IR; Wedell Andersen C; Vibe-Petersen J; Johansen C
Acta Oncol; 2019 May; 58(5):730-736. PubMed ID: 30905247
[No Abstract] [Full Text] [Related]
10. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
O'Dell KJ; Volk RJ; Cass AR; Spann SJ
J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?
Valberg M; Grotmol T; Tretli S; Veierød MB; Moger TA; Devesa SS; Aalen OO
Eur J Epidemiol; 2017 Jun; 32(6):511-520. PubMed ID: 27431530
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
Williams N; Hughes LJ; Turner EL; Donovan JL; Hamdy FC; Neal DE; Martin RM; Metcalfe C
BJU Int; 2011 Nov; 108(9):1402-8. PubMed ID: 21481132
[TBL] [Abstract][Full Text] [Related]
13. Educational level and the risk of depression after prostate cancer.
Friberg AS; Rask Moustsen I; Benzon Larsen S; Hartung T; Wreford Andersen E; Halgren Olsen M; Tjønneland A; Kjaer SK; Johansen C; Brasso K; Oksbjerg Dalton S
Acta Oncol; 2019 May; 58(5):722-729. PubMed ID: 30700197
[No Abstract] [Full Text] [Related]
14. Prostate specific antigen testing is associated with men's psychological and physical health and their healthcare utilisation in a nationally representative sample: a cross-sectional study.
Flahavan EM; Drummond FJ; Bennett K; Barron TI; Sharp L
BMC Fam Pract; 2014 Jun; 15():121. PubMed ID: 24938184
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
16. Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.
Drummond FJ; Carsin AE; Sharp L; Comber H
BMC Fam Pract; 2009 Jan; 10():3. PubMed ID: 19138385
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population.
Orsted DD; Nordestgaard BG; Jensen GB; Schnohr P; Bojesen SE
Eur Urol; 2012 May; 61(5):865-74. PubMed ID: 22104593
[TBL] [Abstract][Full Text] [Related]
19. PSA testing and digital rectal examination in New Zealand.
Sneyd MJ; Cox B; Paul C; Skegg DC
Aust N Z J Public Health; 2003 Oct; 27(5):502-6. PubMed ID: 14651394
[TBL] [Abstract][Full Text] [Related]
20. The impact of socioeconomic status on stage specific prostate cancer survival and mortality before and after introduction of PSA test in Finland.
Seikkula HA; Kaipia AJ; Ryynänen H; Seppä K; Pitkäniemi JM; Malila NK; Boström PJ
Int J Cancer; 2018 Mar; 142(5):891-898. PubMed ID: 29044563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]